ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.96−0.03 (-3.03%)
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ABVC BioPharma's ebitda for the twelve months ending Sep 30, 2023 was -$9.36M. For fiscal 2022 it was -$15.09M. The highest annual figure on record is -$153.40K in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$15.09M | – |
| FY2021 | Dec 31, 2021 | -$11.69M | – |
| FY2013 | Sep 30, 2013 | -$153.40K | – |
| FY2012 | Sep 30, 2012 | -$1.11M | – |
| FY2011 | Sep 30, 2011 | -$1.85M | – |
| FY2010 | Sep 30, 2010 | -$1.84M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$2.15M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$2.19M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$1.90M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$3.13M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$3.71M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$2.04M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$6.21M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$6.44M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$1.97M | – |
See a number that looks wrong?